ASTH
Astrana Health, Inc.
-0.62 (-1.63%)37.09USD391K成交股數2.1B市值45.2本益比(近四季)0.5股價營收比+48.5%營收年增(近四季)2026-11-05下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 0.00 |
| 近 180 天 淨額 | 0.00 |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-05 | 09-09 | Sim Brandon | CEO and President | F 繳稅扣股 | 7.2K | 38.47 | 276K | 1.2M | SEC |
| 2026-09-05 | 09-08 | Basho Chandan | COO and CFO | F 繳稅扣股 | 1.8K | 38.47 | 69K | 158K | SEC |
| 2026-08-31 | 09-01 | Kitayama Mitchell W | Director | D 處分 | 8.5K | 37.09 | 315K | 24.3K | SEC |
| 2026-08-14 | 08-18 | Schmidt David | Director | M 選擇權執行 | 20.0K | 5.00 | 100K | 56.0K | SEC |
| 2026-08-14 | 08-18 | Schmidt David | Director | D 處分 | 20.0K | 38.59 | 772K | 36.0K | SEC |
| 2026-08-07 | 08-11 | Sobotka Glenn | Other | D 處分 | 11.8K | – | – | 2.2K | SEC |
| 2026-06-27 | 06-30 | Sim Brandon | CEO and President | F 繳稅扣股 | 1.1K | 44.51 | 49K | 1.2M | SEC |
| 2026-06-10 | 06-12 | Chiang John | Director | A 獲配股票 | 4.5K | – | – | 35.4K | SEC |
| 2026-06-10 | 06-12 | Schmidt David | Director | A 獲配股票 | 4.5K | – | – | 36.0K | SEC |
| 2026-06-10 | 06-12 | Mazdyasni Matthew | Director | A 獲配股票 | 4.5K | – | – | 39.3K | SEC |
| 2026-06-10 | 06-12 | Dong Linda | Director | A 獲配股票 | 4.5K | – | – | 97.1K | SEC |
| 2026-06-10 | 06-12 | Kitayama Mitchell W | Director | A 獲配股票 | 5.0K | – | – | 32.8K | SEC |
| 2026-06-10 | 06-12 | Dai, Weili | Director | A 獲配股票 | 4.5K | – | – | 18.2K | SEC |
| 2026-05-16 | 05-18 | Basho Chandan | COO and CFO | F 繳稅扣股 | 8.2K | 38.26 | 312K | 160K | SEC |
| 2026-04-14 | 04-15 | Basho Chandan | COO and CFO | F 繳稅扣股 | 3.9K | 29.07 | 113K | 168K | SEC |
| 2026-04-06 | 04-08 | Sim Brandon | CEO and President | A 獲配股票 | 201K | – | – | 1.2M | SEC |
| 2026-04-06 | 04-08 | Lam Thomas S. | Director | A 獲配股票 | 41.7K | – | – | 466K | SEC |
| 2026-04-06 | 04-08 | Sim Kenneth T. | Executive Chairman | A 獲配股票 | 100K | – | – | 739K | SEC |
| 2026-04-02 | 04-03 | Basho Chandan | COO and CFO | F 繳稅扣股 | 2.1K | 25.05 | 52K | 172K | SEC |
| 2026-04-01 | 04-03 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 58.0K | 24.51 | 1.4M | 178K | SEC |
| 2026-04-01 | 04-03 | Kumar Dinesh M. | Chief Medical Officer | A 獲配股票 | 35.3K | – | – | 236K | SEC |
| 2026-03-26 | 03-30 | Sobotka Glenn | Chief Accounting Officer | F 繳稅扣股 | 662 | 24.27 | 16K | 14.0K | SEC |
| 2026-03-05 | 03-09 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 1.7K | 25.07 | 43K | 200K | SEC |
| 2026-03-05 | 03-09 | Basho Chandan | COO and CFO | F 繳稅扣股 | 1.2K | 25.07 | 31K | 174K | SEC |
| 2026-03-05 | 03-09 | Lam Thomas S. | Director | F 繳稅扣股 | 9.3K | 25.07 | 232K | 424K | SEC |
| 2026-02-02 | 02-03 | Sim Brandon | CEO and President | M 選擇權執行 | 21.3K | 23.24 | 496K | 1.0M | SEC |
| 2026-01-23 | 01-27 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 10.8K | 27.16 | 292K | 202K | SEC |
| 2026-01-13 | 01-15 | Schmidt David | Director | F 繳稅扣股 | 4.3K | 27.12 | 116K | 31.5K | SEC |
| 2026-01-13 | 01-15 | Schmidt David | Director | M 選擇權執行 | 20.0K | 5.79 | 116K | 35.8K | SEC |
| 2026-01-01 | 01-05 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 5.1K | 24.81 | 127K | 213K | SEC |
| 2025-12-08 | 12-10 | Lam Thomas S. | Director | F 繳稅扣股 | 25.9K | 22.00 | 569K | 433K | SEC |
| 2025-12-08 | 12-10 | Lam Thomas S. | Director | M 選擇權執行 | 29.5K | 17.78 | 525K | 459K | SEC |
| 2025-11-10 | 11-13 | Sim Kenneth T. | Executive Chairman | M 選擇權執行 | 29.5K | 17.78 | 525K | 639K | SEC |
| 2025-11-10 | 11-12 | Mazdyasni Matthew | Director | M 選擇權執行 | 20.0K | 18.20 | 364K | 34.8K | SEC |
| 2025-11-07 | 11-12 | Kitayama Mitchell W | Director | M 選擇權執行 | 12.0K | 18.20 | 218K | 27.8K | SEC |
| 2025-11-03 | 11-05 | Marsh Linda | Director | F 繳稅扣股 | 11.0K | 32.99 | 364K | 92.6K | SEC |
| 2025-11-03 | 11-05 | Marsh Linda | Director | M 選擇權執行 | 20.0K | 18.20 | 364K | 104K | SEC |
| 2025-10-02 | 10-06 | Basho Chandan | COO and CFO | F 繳稅扣股 | 2.0K | 27.77 | 55K | 175K | SEC |
| 2025-09-15 | 09-15 | Kitayama Mitchell W | Director | M 選擇權執行 | 8.0K | 18.20 | 146K | 29.1K | SEC |
| 2025-09-15 | 09-15 | Kitayama Mitchell W | Director | D 處分 | 5.2K | 30.23 | 158K | 15.8K | SEC |
| 2025-09-15 | 09-15 | Kitayama Mitchell W | Director | D 處分 | 8.0K | 30.23 | 242K | 21.1K | SEC |
| 2025-09-05 | 09-09 | Basho Chandan | COO and CFO | F 繳稅扣股 | 1.7K | 29.70 | 50K | 177K | SEC |
| 2025-09-05 | 09-09 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 1.7K | 29.70 | 50K | 218K | SEC |
| 2025-09-02 | 09-03 | Schmidt David | Director | D 處分 | 20.0K | 27.76 | 555K | 15.8K | SEC |
| 2025-09-02 | 09-03 | Schmidt David | Director | M 選擇權執行 | 20.0K | 18.20 | 364K | 35.8K | SEC |
| 2025-08-13 | 08-14 | Chiang John | Director | M 選擇權執行 | 20.0K | 18.20 | 364K | 43.1K | SEC |
| 2025-08-13 | 08-14 | Chiang John | Director | F 繳稅扣股 | 12.3K | 29.63 | 364K | 30.8K | SEC |
| 2025-07-01 | 07-02 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 6.8K | 25.06 | 171K | 219K | SEC |
| 2025-06-11 | 06-13 | Schmidt David | Director | A 獲配股票 | 6.4K | – | – | 15.8K | SEC |
| 2025-06-11 | 06-13 | Kitayama Mitchell W | Director | A 獲配股票 | 6.4K | – | – | 21.1K | SEC |
| 2025-06-11 | 06-13 | Marsh Linda | Director | A 獲配股票 | 6.4K | – | – | 83.6K | SEC |
| 2025-06-11 | 06-13 | Dai, Weili | Director | A 獲配股票 | 6.4K | – | – | 13.7K | SEC |
| 2025-06-11 | 06-13 | Chiang John | Director | A 獲配股票 | 6.4K | – | – | 23.1K | SEC |
| 2025-06-11 | 06-13 | Mazdyasni Matthew | Director | A 獲配股票 | 6.4K | – | – | 14.8K | SEC |
| 2025-06-04 | 06-06 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 1.7K | 25.06 | 41K | 226K | SEC |
| 2025-05-16 | 05-19 | Basho Chandan | COO and CFO | F 繳稅扣股 | 10.0K | 27.18 | 273K | 179K | SEC |
| 2025-04-29 | 04-30 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 828 | 31.15 | 26K | 227K | SEC |
| 2025-04-14 | 04-16 | Basho Chandan | COO and CFO | F 繳稅扣股 | 2.7K | 34.05 | 91K | 189K | SEC |
| 2025-04-02 | 04-03 | Basho Chandan | COO and CFO | F 繳稅扣股 | 1.4K | 30.02 | 42K | 191K | SEC |
| 2025-03-26 | 03-28 | Sobotka Glenn | Chief Accounting Officer | A 獲配股票 | 8.3K | – | – | 14.7K | SEC |
| 2025-03-26 | 03-28 | Sobotka Glenn | Chief Accounting Officer | A 獲配股票 | 6.4K | – | – | 6.4K | SEC |
| 2025-03-05 | 03-07 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 7.9K | 27.19 | 214K | 228K | SEC |
| 2025-03-05 | 03-07 | Basho Chandan | COO and CFO | A 獲配股票 | 26.7K | – | – | 193K | SEC |
| 2025-03-05 | 03-07 | Lam Thomas S. | Director | F 繳稅扣股 | 9.2K | 27.19 | 251K | 430K | SEC |
| 2025-03-05 | 03-07 | Sim Brandon | CEO and President | A 獲配股票 | 146K | – | – | 1.1M | SEC |
| 2025-03-05 | 03-07 | Kumar Dinesh M. | Chief Medical Officer | A 獲配股票 | 26.7K | – | – | 236K | SEC |
| 2025-03-05 | 03-07 | Sim Brandon | CEO and President | F 繳稅扣股 | 106K | 27.19 | 2.9M | 1.0M | SEC |
| 2025-02-15 | 02-18 | Lam Thomas S. | Director | J 其他 | 700K | – | – | 6.1M | SEC |
| 2025-02-15 | 02-18 | Sim Kenneth T. | Executive Chairman | J 其他 | 26.2K | – | – | 546K | SEC |
| 2025-02-15 | 02-18 | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | TenPercentOwner | J 其他 | 700K | – | – | 6.1M | SEC |
| 2025-02-15 | 02-18 | Lam Thomas S. | Director | J 其他 | 26.2K | – | – | 1.1M | SEC |
| 2025-02-15 | 02-18 | Sim Kenneth T. | Executive Chairman | J 其他 | 700K | – | – | 6.1M | SEC |
| 2025-01-23 | 01-27 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 7.2K | 37.96 | 274K | 209K | SEC |
| 2025-01-17 | 01-22 | ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp | TenPercentOwner | D 處分 | 300K | 35.17 | 10.6M | 6.8M | SEC |
| 2025-01-17 | 01-22 | Sim Kenneth T. | Executive Chairman | D 處分 | 300K | 35.17 | 10.6M | 6.8M | SEC |
| 2025-01-17 | 01-22 | Lam Thomas S. | Director | D 處分 | 300K | 35.17 | 10.6M | 6.8M | SEC |
| 2025-01-01 | 01-03 | Kumar Dinesh M. | Chief Medical Officer | F 繳稅扣股 | 967 | 31.53 | 30K | 216K | SEC |
| 2024-12-10 | 12-12 | Kitayama Mitchell W | Director | D 處分 | 5.1K | 43.09 | 220K | 14.6K | SEC |
| 2024-11-30 | 12-03 | Vong John | Chief Accounting Officer | F 繳稅扣股 | 134 | 43.25 | 6K | 17.5K | SEC |
| 2024-11-22 | 11-26 | Kitayama Mitchell W | Director | M 選擇權執行 | 3.4K | 18.41 | 63K | 21.2K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| BlackRock, Inc. | 6.9M | 320M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.6M | 121M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.9M | 90.3M | 新進 | 新進 |
| STATE STREET CORP | 1.7M | 80.7M | 新進 | 新進 |
| 325 CAPITAL LLC | 1.6M | 74.9M | 新進 | 新進 |
| DIMENSIONAL FUND ADVISORS LP | 1.5M | 68.1M | 新進 | 新進 |
| WELLINGTON MANAGEMENT GROUP LLP | 1.3M | 60.0M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2M | 54.2M | 新進 | 新進 |
| BANK OF AMERICA CORP /DE/ | 852K | 39.5M | 新進 | 新進 |
| FMR LLC | 686K | 31.8M | 新進 | 新進 |
| WELLS FARGO & COMPANY/MN | 665K | 30.9M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 653K | 30.3M | 新進 | 新進 |
| AMERIPRISE FINANCIAL INC | 512K | 23.8M | 新進 | 新進 |
| NORTHERN TRUST CORP | 505K | 23.4M | 新進 | 新進 |
| Diamond Hill Capital Management, LLC (Investment Advisor) | 476K | 22.1M | 新進 | 新進 |
| ROYCE & ASSOCIATES LP | 472K | 21.9M | 新進 | 新進 |
| SteelPeak Wealth, LLC | 465K | 21.6M | 新進 | 新進 |
| MORGAN STANLEY | 434K | 20.1M | 新進 | 新進 |
| Invesco Ltd. | 382K | 17.7M | 新進 | 新進 |
| VANGUARD FIDUCIARY TRUST CO | 307K | 14.2M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 272K | 12.6M | 新進 | 新進 |
| PRINCIPAL FINANCIAL GROUP INC | 268K | 12.4M | 新進 | 新進 |
| EARNEST PARTNERS LLC | 259K | 12.0M | 新進 | 新進 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 249K | 11.6M | 新進 | 新進 |
| Bank of New York Mellon Corp | 235K | 10.9M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 209 +38 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 209 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 32.1M · 57.7% |
| 合計季末市值 | 1.5B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.3M |
|---|---|
| 與上期比 | +3.0% |
| 佔流通股數 | 5.89% |
| 日均成交量 | 336K |
| 回補天數 | 9.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.3M | +3.0% | 5.89% | 336K | 9.8 |
| 2026-08-14 | 3.2M | +12.6% | 5.71% | 567K | 5.6 |
| 2026-07-31 | 2.8M | +5.5% | 5.07% | 573K | 4.9 |
| 2026-07-15 | 2.7M | +0.2% | 4.81% | 686K | 3.9 |
| 2026-06-30 | 2.7M | +13.4% | 4.80% | 870K | 3.1 |
| 2026-06-15 | 2.4M | -1.7% | 4.23% | 522K | 4.5 |
| 2026-05-29 | 2.4M | -11.7% | 4.30% | 390K | 6.2 |
| 2026-05-15 | 2.7M | -5.1% | 4.87% | 534K | 5.1 |
| 2026-04-30 | 2.9M | +6.6% | 5.13% | 512K | 5.6 |
| 2026-04-15 | 2.7M | -6.4% | 4.82% | 373K | 7.2 |
| 2026-03-31 | 2.9M | +10.3% | 5.15% | 391K | 7.3 |
| 2026-03-13 | 2.6M | -11.1% | 4.66% | 713K | 3.7 |
| 2026-02-27 | 2.9M | +3.0% | 5.25% | 359K | 8.1 |
| 2026-02-13 | 2.8M | +10.7% | 5.09% | 604K | 4.7 |
| 2026-01-30 | 2.6M | +0.1% | 4.60% | 617K | 4.2 |
| 2026-01-15 | 2.6M | -7.0% | 4.59% | 485K | 5.3 |
| 2025-12-31 | 2.8M | -7.7% | 4.94% | 542K | 5.1 |
| 2025-12-15 | 3.0M | +25.3% | 5.35% | 495K | 6.0 |
| 2025-11-28 | 2.4M | -0.1% | 4.27% | 536K | 4.4 |
| 2025-11-14 | 2.4M | +18.6% | 4.28% | 737K | 3.2 |
| 2025-10-31 | 2.0M | +20.2% | 3.61% | 335K | 6.0 |
| 2025-10-15 | 1.7M | -3.2% | 3.00% | 261K | 6.4 |
| 2025-09-30 | 1.7M | +11.4% | 3.10% | 384K | 4.5 |
| 2025-09-15 | 1.5M | +0.5% | 2.78% | 341K | 4.6 |
| 2025-08-29 | 1.5M | -6.9% | 2.77% | 331K | 4.7 |
| 2025-08-15 | 1.7M | +3.1% | 2.97% | 632K | 2.6 |